Furthermore, ELAVL2 was found to be deleted mostly in grade IV glioma, GBM, IDH-wt glioma, and GBMs of classical and MES molecular subtypes, all of which define the aggressive phenotypes of glioma (Fig. 1f). This evidence concerns the gene ELAVL2 and central nervous system cancer.